Recombinant PDCD1 (Pembrolizumab Biosimilar) antibody (Biotin)
The Humanized Monoclonal anti-PDCD1 (Pembrolizumab Biosimilar) antibody has been validated for FACS, ELISA and CyTox. It is suitable to detect PDCD1 (Pembrolizumab Biosimilar) in samples from Human.
Catalog No. ABIN7766341
$515.90
Plus shipping costs $50.00
100 μL
Shipping to:
United States
Delivery in 6 to 8 Business Days
Quick Overview for Recombinant PDCD1 (Pembrolizumab Biosimilar) antibody (Biotin) (ABIN7766341)
Target
PDCD1 (Pembrolizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Conjugate
This PDCD1 (Pembrolizumab Biosimilar) antibody is conjugated to Biotin
Application
Flow Cytometry (FACS), ELISA, Cytotoxicity Test (CyTox)
-
-
Purpose
- Conjugated Anti-PD-1 (pembrolizumab biosimilar) mAb
-
Purification
- Purified from cell culture supernatant by affinity chromatography
-
-
anti-PDCD1 (Pembrolizumab Biosimilar) antibody
Research Grade Reactivity: Human FACS, ELISA Host: Humanized Monoclonal unconjugated Recombinant Antibody
-
-
Application Notes
- working with enzyme-conjugated streptavidin, most applications: 1: 50 - 1: 1,000
-
Restrictions
- For Research Use only
-
-
-
Buffer
- Liquid in PBS, 0.5 % BSA, 40 % Glycerol, 0.02 % Sodium Azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Protect from light!
-
Storage
- 4 °C
-
Storage Comment
- Store at 4°C in dark for 6 months
-
-
- PDCD1 (Pembrolizumab Biosimilar)
-
Alternative Name
- pembrolizumab biosimilar
-
Target Type
- Biosimilar
-
Background
- PDCD1, PD1, CD279, SLEB2
Target
-
You are here:
